Home › Free Stock Grades › GKOS
Glaukos Corporation (GKOS) Stock Grade
GKOS · Healthcare
A+
Market Cap
$6.5B
P/E Ratio
—
Revenue Growth (YoY)
+32.3%
Net Margin
-37.0%
Return on Equity
—
Dividend Yield
None
About Glaukos Corporation's fundamentals
Glaukos Corporation is a $6.5 billion healthcare devices company experiencing strong revenue expansion at 32.3% year-over-year growth, indicating robust demand for its products. However, the company is currently unprofitable, with a net margin of -37.0%, and reported a net loss in its latest annual statement, meaning it is spending substantially more than it generates in revenue. The company does not pay a dividend, typical for growth-stage medical device firms that reinvest losses and cash into product development and market expansion.